Skip to main content
Log in

Upregulation of miR-222 in both Helicobacter pylori-infected and noninfected gastric cancer patients

  • RESEARCH ARTICLE
  • Published:
Journal of Genetics Aims and scope Submit manuscript

Abstract

Despite of promising improvements in treatment of gastric cancer, the mortality rate of this malignancy remains high. Chronic infection by Helicobacter pylori, interfering with intracellular signalling pathways, is the main risk factor for gastric cancer. Some evidence suggests that microRNAs (miRNA), the small noncoding RNA molecules, can play role as oncogenes or tumour suppressors in the cells. MiR-222 is one of the remarkable miRNAs undergoing upregulation in gastric cancer. However, the association between miR-222 upregulation and H. pylori infection in gastric cancer tissues remains unclear. The aim of this study was to analyse the expression level of miR-222 in gastric cancer tissues, evaluating the relationship between miR-222 expression level and H. pylori infection and also finding novel miR-222 targets based on in silico investigations. MiR-222 expression level in 200 patients including 112 H. pylori positive and 88 H. pylori negative was relatively measured using RT-qPCR and compared with 88 healthy samples. In silico enrichment analysis of miR-222 targets was performed by DAVID database to evaluate the possible role(s) of miR-222 in gastric tumourigenesis. We observed upregulated level of miR-222 in gastric cancer tissues compared with normal samples (P < 0.05). However, no significant difference between miR-222 expression in H. pylori-positive and H. pylori-negative cases was observed. Our in silico analyses showed the possible role of p53, p27, PTEN and Elongin B in gastric cancer tumourigenesis. MiR-222 functions as an onco-miRNA and its overexpression can be involved in pathogenesis of gastric cancer, independent of H. pylori infection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Bartel D. P. 2004 MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281–297.

    Article  CAS  PubMed  Google Scholar 

  • Catalano V., Labianca R., Beretta G. D., Gatta G., de Braud F. and Van Cutsem E. 2005 Gastric cancer. Crit. Rev. Oncol. Hematol. 54, 209–241.

    Article  PubMed  Google Scholar 

  • Chun-Zhi Z., Lei H., An-Ling Z., Yan-Chao F., Xiao Y., Guang-Xiu W. et al. 2010 MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN. BMC Cancer 10, 367.

    Article  PubMed  PubMed Central  Google Scholar 

  • Cotticelli L., Borrelli M., D’Alessio A., Menzione M., Villani A., Piccolo G. et al. 2005 Central serous chorioretinopathy and Helicobacter pylori. Eur. J. Ophthal. 16, 274–278.

    Google Scholar 

  • Fu Z., Qian F., Yang X., Jiang H., Chen Y. and Liu S. 2014 Circulating miR-222 in plasma and its potential diagnostic and prognostic value in gastric cancer. Med. Oncol. 31, 1–8.

    Article  CAS  Google Scholar 

  • González C. A., Sala N. and Rokkas T. 2013 Gastric cancer: epidemiologic aspects. Helicobacter 18, 34–38.

    Article  PubMed  Google Scholar 

  • Jakszyn P. and González C. A. 2006 Nitrosamine and related food intake and gastric and oesophageal cancer risk: A systematic review of the epidemiological evidence. World J. Gastroenterol 12, 4296–4303.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kim Y. -K., Yu J., Han T. S., Park S. -Y., Namkoong B., Kim D. H. et al. 2009 Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res. 37, 1672–1681.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Le Sage C., Nagel R., Egan D. A., Schrier M., Mesman E., Mangiola A. et al. 2007 Regulation of the p27Kip1 tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J. 26, 3699–3708.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Li N., Tang B., Zhu E. -D., Li B. -S., Zhuang Y., Yu S. et al. 2012 Increased miR-222 in H. pylori-associated gastric cancer correlated with tumor progression by promoting cancer cell proliferation and targeting RECK. FEBS Lett. 586, 722–728.

    Article  CAS  PubMed  Google Scholar 

  • Li N., Yu N., Wang J., Xi H., Lu W., Xu H. et al. 2014 miR-222/VGLL4/YAP-TEAD1 regulatory loop promotes proliferation and invasion of gastric cancer cells. Am. J. Cancer Res. 5, 1158–1168.

    Google Scholar 

  • Li X., Zhang Y., Zhang H., Liu X., Gong T., Li M. et al. 2011 miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. Mol. Cancer Res. 9, 824–833.

    Article  CAS  PubMed  Google Scholar 

  • Livak K. J. and Schmittgen T. D. 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2 −ΔΔCT method. Methods 25, 402–408.

    Article  CAS  PubMed  Google Scholar 

  • Nomura M., Nakano S., Kudou J., Ishibashi O. and Niho Y. 1990 Successful treatment of advanced gastric cancer with multiple liver metastasis by combination chemotherapy using mitomycin C, 5-fluorouracil, and high-dose leucovorin: a case report. Gan to kagaku ryoho. Cancer & Chemother. 17, 2097–2100.

    CAS  Google Scholar 

  • Noto J. M. and Peek R. M. 2012 Gastric-to-intestinal transdifferentiation and cancer. Proc. Natl. Acad. Sci. 109, 20173–20174.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sugerman P., Joseph B. and Savage N. 1995 The role of oncogenes, tumour suppressor genes and growth factors in oral squamous cell carcinoma: a case of apoptosis versus proliferation. Oral Dis. 1, 172–188.

    Article  CAS  PubMed  Google Scholar 

  • Thrumurthy S. G., Chaudry M. A., Hochhauser D. and Mughal M. 2013 The diagnosis and management of gastric cancer. BMJ 347, 6367.

    Article  Google Scholar 

  • Torre L. A., Bray F., Siegel R. L., Ferlay J., Lortet-Tieulent J. and Jemal A. 2015 Global cancer statistics, 2012. CA: J. Clin. 65, 87–108.

    Article  Google Scholar 

  • Wang M., Zhao C., Shi H., Zhang B., Zhang L., Zhang X. et al. 2014 Deregulated microRNAs in gastric cancer tissue-derived mesenchymal stem cells: novel biomarkers and a mechanism for gastric cancer. Br. J. Cancer 110, 1199–1210.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zabaleta J. 2012 MicroRNA: a bridge from H. pylori infection to gastritis and gastric cancer development. Front. Genet. 3, 294.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We strongly appreciate staffs of Al-Zahra Hospital, blood donors and our colleagues in Zist-Fanavari Novin Biotechnology Institute, for their constructive comments and participations.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to KAMRAN GHAEDI.

Additional information

Corresponding editor: J. Gowrishankar

[Noormohammad M., Sadeghi S., Tabatabaeian H., Ghaedi K., Talebi A., Azadeh M., Khatami M. and Heidari M. M. 2016. Upregulation of miR-222 in both Helicobacter pylori-infected and noninfected gastric cancer patients. J. Genet. 95, xx–xx]

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

NOORMOHAMMAD, M., SADEGHI, S., TABATABAEIAN, H. et al. Upregulation of miR-222 in both Helicobacter pylori-infected and noninfected gastric cancer patients. J Genet 95, 991–995 (2016). https://doi.org/10.1007/s12041-016-0728-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12041-016-0728-9

Keywords

Navigation